Liraglutide for patients with non-alcoholic steatohepatitis.
Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
Aaron
A
Dale
Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
Philip
P
Hartley
Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: compare-team@ebmdatalab.net.
Carl
C
Heneghan
D005260:Female; D006801:Humans; D054795:Incretins / Q000008:administration & dosage*; D000069450:Liraglutide / Q000008:administration & dosage*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*
D054795:Incretins; D000069450:Liraglutide